NOVAVAX INC (NVAX)       11.29  +0.31 (+2.82%)

11.29  +0.31 (+2.82%)

US6700024010 - Common Stock - Premarket: 11.12 -0.17 (-1.51%)

TTM
(2022-9-30)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
2018
(2018-12-31)
Revenue
1.85B1.15B475.60M18.70M34.30M
Non Recurring Items
N/A0.000.009.00MN/A
Cost Of Goods
N/AN/AN/AN/AN/A
Gross Profit
N/AN/AN/AN/AN/A
Operating Expenses
2.35B2.83B892.30M148.20M208.20M
Operating Income
N/AN/AN/AN/AN/A
Interest Expense
-20.31M-26.96M-14.10M-12.10M-10.90M
Income Before Taxes
-1.30B-1.71B-418.30M-132.70M-184.70M
Income Tax
23.16M29.21MN/AN/AN/A
Net Income
-1.32B-1.74B-418.30M-132.70M-184.70M
EBITDA
N/AN/AN/AN/AN/A
 
Per Share Data
EPS Diluted Total Ops
-17.25-23.44-7.26-5.51-9.98
Non GAAP EPS
-17.30-23.29-6.79-6.13-10.20
 
Statistics
Gross Profit Margin
N/AN/AN/AN/AN/A
Profit Margin
-71.59%-152.12%-87.95%-709.63%-538.48%
Operating Profit Margin
N/AN/AN/AN/AN/A

All data in USD

Charts